Biocon sees larger licensing income from pharmaceuticals business
Bangalore, Thursday, Januray 26, 2012: Biocon Ltd, India's top-listed biotechnology company, expects to generate larger licensing income from pharmaceuticals business, its Chairman and Managing Director said on Wednesday.

The Bangalore-based drugmaker earlier said consolidated net profit fell 15.8 percent in December quarter, while revenue rose 3 percent.

The sales growth in the fiscal third quarter ended Dec. 31 was flat on lower licensing income, Kiran Mazumdar-Shaw, told a TV channel.

The company said, licensing fees and income dropped to 292 million rupees in October-December from 768 million rupees a year earlier.

Ref: ET